Moreover, elevated CBX2 levels were significantly associated with age ≥ 45 years, lymph vascular invasion, lymph node metastasis, and tumor size ≥ 4 cm (Fig. 1F and Table 1), indicating a tumor-promoting role of CBX2 in cervical cancer. This evidence concerns the gene CBX2 and cervical cancer.